(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

USOS DE COMPOSTO ANTAGONISTA DE C5AR

Em AnáliseUtility ModelPCT · US2017013132

Application data

Utility Model USOS DE COMPOSTO ANTAGONISTA DE C5AR de CHEMOCENTRYX, INC. — IPC A61K 31/517
Utility Model USOS DE COMPOSTO ANTAGONISTA DE C5AR de CHEMOCENTRYX, INC. — IPC A61K 31/517. Drawing published by the INPI in the Industrial Property Gazette.

Number

122024002810

Type

Utility Model

Filing

01/12/2017

Publication

03/12/2024

PCT

US2017013132

Progress at the INPI

Under appeal
  1. Filing01/12/17
  2. Publication03/12/24
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application is under appeal: the INPI has yet to review the decision.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 11/19/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

CHEMOCENTRYX, INC.

US

See this company's full portfolio

Inventors

P. B. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

62/278,788 · 01/14/2016

US

62/280,346 · 01/19/2016

US

62/347,450 · 06/08/2016

US

62/397,527 · 09/21/2016

Abstract

USOS DE COMPOSTO ANTAGONISTA DE C5AR. A presente invenção refere-se a métodos de tratamento de um ser humano que sofre de ou está suscetível à glomerulopatia C3 compreendendo administrar ao ser humano uma quantidade eficaz de um antagonista de C5aR.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Petição de recurso

#12.2

Recurso: 870240095703 - 7/11/2024

11/19/2024

RPI 2811

Indeferimento

#9.2

09/10/2024

RPI 2801

Publicação do pedido de patente

#3.1

03/12/2024

RPI 2775

Notificação de pedido dividido

#2.4

03/05/2024

RPI 2774

Requerimento de pedido de patente

#2.10

Número de Protocolo '870240011932' em 09/02/2024 17:43 (WB)

02/20/2024

RPI 2772

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.